Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Cancer Immunol Res (2022) 10 (8): 996–1012.

https://doi.org/10.1158/2326-6066.CIR-21-0870

Published: 03 August 2022

View article titled, Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Includes: Supplementary data

Journal Articles

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Cancer Immunol Res (2021) 9 (5): 554–567.

https://doi.org/10.1158/2326-6066.CIR-20-0905

Published: 01 May 2021

View article titled, Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Includes: Supplementary data

Journal Articles

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Cancer Immunol Res (2020) 8 (11): 1365–1380.

https://doi.org/10.1158/2326-6066.CIR-19-0005

Published: 02 November 2020

View article titled, Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Includes: Supplementary data

Journal Articles

Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma

Ashvin R. Jaiswal, Shivanand Pudakalakatti, Prasanta Dutta, Arthur Liu, Todd Bartkowiak, Casey Ager, Cristina Ivan, Richard Eric Davis, Michael A. Davies, Jennifer Wargo, James P. Allison, Pratip K. Bhattacharya, David Hong, Michael A. Curran

Cancer Immunol Res (2018) 6 (9_Supplement): PR08.

https://doi.org/10.1158/2326-6074.TUMIMM17-PR08

Published: 01 September 2018

View article titled, Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma

Journal Articles

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report

Isabella C. Glitza, Cara Haymaker, Chantale Bernatchez, Luis Vence, Michelle Rohlfs, Jessie Richard, Carol Lacey, Rahmatu Mansaray, Orenthial J. Fulbright, Renjith Ramachandran, Christopher Toth, Seth Wardell, Sapna P. Patel, Scott E. Woodman, Wen-Jen Hwu, Laszlo G. Radvanyi, Michael A. Davies, Nicholas E. Papadopoulos, Patrick Hwu

Cancer Immunol Res (2015) 3 (11): 1201–1206.

https://doi.org/10.1158/2326-6066.CIR-15-0071

Published: 04 November 2015

View article titled, Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report

Journal Articles

Abstract A62: Immune and T cell receptor heterogeneity in distinct tumors within individual melanoma patients

Alexandre Reuben, Rodabe N. Amaria, Cara Haymaker, Marie Andree Forget, Chantale Bernatchez, Pei-ling Chen, Michael Tetzlaff, Michael A. Davies, Karen C. Dwyer, Jennifer A. Wargo, Zachary A. Cooper

Cancer Immunol Res (2015) 3 (10_Supplement): A62.

https://doi.org/10.1158/2326-6074.TUMIMM14-A62

Published: 09 October 2015

View article titled, Abstract A62: Immune and T cell receptor heterogeneity in distinct tumors within individual melanoma patients

Journal Articles

BRAF^V600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8⁺ T-cell Recognition of Melanoma

Sherille D. Bradley, Zeming Chen, Brenda Melendez, Amjad Talukder, Jahan S. Khalili, Tania Rodriguez-Cruz, Shujuan Liu, Mayra Whittington, Wanleng Deng, Fenge Li, Chantale Bernatchez, Laszlo G. Radvanyi, Michael A. Davies, Patrick Hwu, Gregory Lizée

Cancer Immunol Res (2015) 3 (6): 602–609.

https://doi.org/10.1158/2326-6066.CIR-15-0030

Published: 03 June 2015

View article titled, BRAF<sup>V600E</sup> Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8<sup>+</sup> T-cell Recognition of Melanoma

Includes: Supplementary data

NARROW

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report

Abstract A62: Immune and T cell receptor heterogeneity in distinct tumors within individual melanoma patients

BRAF^V600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8⁺ T-cell Recognition of Melanoma

Email alerts

AACR Journals

Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition

Targeted Therapy Given after Anti–PD-1 Leads to Prolonged Responses in Mouse Melanoma Models through Sustained Antitumor Immunity

Melanoma Evolves Complete Immunotherapy Resistance through the Acquisition of a Hypermetabolic Phenotype

Abstract PR08: Metabolic adaptations establish immunotherapy resistance in melanoma

Intrathecal Administration of Tumor-Infiltrating Lymphocytes Is Well Tolerated in a Patient with Leptomeningeal Disease from Metastatic Melanoma: A Case Report

Abstract A62: Immune and T cell receptor heterogeneity in distinct tumors within individual melanoma patients

BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

BRAF^V600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8⁺ T-cell Recognition of Melanoma